ALR Press Materials and Links
Breaking News
We are pleased to announce a multi-million dollar lupus drug development deal between GlaxoSmithKlino and Dynavax Technologies Corporation. The deal covers four separate programs, including one to develop treatment specifically for lupus. Data from previously ALR-funded research supported the early development of this potential new treatment for lupus. Read more about this exciting news below:
December 17, 2008 - Yahoo! Finance
GlaxoSmithKline, Dynavax agree to $800M drug development deal
December 17, 2008 - Triangle Business Journal
Click Here for Recent ALR Press Releases
Human Interest Items
Atlanta Journal-Constitution
"Lupus walk helps family deal with loss"
October 24, 2008
Paso Robles Press
"Locals set for walk to battle Lupus"
October 23, 2008
Sullivan County Democrat
"They Walk for Karen"
August 29, 2008
Petoskey News-Review
"Lupus: When the immune system attacks its own body"
July 18, 2008
Petoskey News-Review
Bob-In Again Restaurant presents a $600 check to Amy Gillard
July 9, 2008
West Seattle Blog
"West Seattle Sunday Scenes"
May 18,2008
The Globe
"Hundreds Participate in Walk with Us to Cure Lupus"
December 12, 2007
ALR In the News
Chattanooga Times Free Press
Take a walk Saturday to help find a cure for lupus
October 3, 2008
My9 News Blog with Brenda Blackmon
"A Thank You Note"
October 5, 2008
Business Wire
Charity partners with Mpayy to Enable Secure Fundraising across Social Networks and Blogs
July 15, 2008
The Graphic Weekly
"Walk with Us to Cure Lupus"
June 19, 2008
Lupus In the News
Kansas Public Radio
"New Hope for Lupus Patients"
July 21, 2008
Petoskey News-Review
"A limited number of men affected by lupus"
July 18,2008
Research Items
Research in the News
Oklahoma Medical Research Foundation
"The X Factor
OMRF scientist finds genetic link between X chromosomes and lupus"
March 5, 2008
www.bloomberg.com
Lupus-Linked Genes Doubled by Research Into Causes, Treatment
John Lauermann
January 20, 2008
Scientific Publications
Journal of Immunology
"Activated Renal Macrophages Are Markers of Disease Onset and Disease
Remission in Lupus Nephritis"
March 15, 2008
Clinical Immunology
"A longitudinal analysis of SLE patients treated with rituximab (anti-CD20): Factors associated with B lymphocyte recovery"
January 15, 2008
Expert Reviews in Molecular Medicine
"Targeting of the immune system in sytemic lupus erythematosus"
Nature Genetics
"Genome - wide association seen in women with systemic lupus erythematosus identifies susceptibility varients in ITGAM, PXK, KIAA1542 and other loci"
February 2008
Disclaimer
The links herein provide content that might be of interest to our visitors. We are not responsible for the material at other sites to which we have established links and establishing a link does not constitute an endorsement of that material.
The information displayed by the sites we link to is no substitute for expert medical care. We recommend that you discuss your condition and any information you may obtain about it with your physician.
Our mission is to prevent, treat and cure lupus through medical research. 100% of all donations go to support medical research.
Donate Today